Anais Malpica
Overview
Explore the profile of Anais Malpica including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
212
Citations
4250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Louro L, Miranda R, Medeiros L, Malpica A, Marques-Piubelli M, Ramalingam P
Ann Diagn Pathol
. 2024 Nov;
74:152397.
PMID: 39608291
Fibrin-associated large B-cell lymphoma (FA-LBCL) is a rare type of lymphoma usually associated with Epstein-Barr virus (EBV) infection. We report a case incidentally detected in a right ovarian mass of...
2.
Lawson B, Marques-Piubelli M, Westin S, Malpica A
Int J Gynecol Pathol
. 2024 Jun;
44(2):167-173.
PMID: 38914019
Folate receptor alpha has been shown to have possible mechanisms of tumorigenesis in malignancies, becoming a potential target for therapy. Mirvetuximab soravtansine is an antifolate receptor alpha monoclonal antibody, with...
3.
Euscher E, Marques-Piubelli M, Ramalingam P, Wistuba I, Lawson B, Frumovitz M, et al.
Am J Surg Pathol
. 2023 Apr;
47(6):635-648.
PMID: 37026792
Extrauterine mesonephric-like carcinoma (ExUMLC) shares histologic, immunohistochemical (IHC), and molecular (MOL) features with endometrial mesonephric-like carcinoma (EnMLC). Its rarity and histologic overlap with Mullerian carcinomas contribute to underrecognition of ExUMLC....
4.
Zhang X, Yao J, Niu N, Li X, Liu Y, Huo L, et al.
Mod Pathol
. 2023 Feb;
36(2):100001.
PMID: 36853778
PAX8 is the most commonly used immunomarker to link a carcinoma to the gynecologic tract; however, it lacks specificity. Through mining The Cancer Genome Atlas mRNA expression profile data, we...
5.
Malpica A
Adv Anat Pathol
. 2023 Feb;
30(4):262-274.
PMID: 36729766
A remarkable amount of new information has been generated on peritoneal mesothelioma (PeM), ranging from nomenclature changes, including the removal of "malignant" when referring to this neoplasm and the use...
6.
Wong K, Bateman N, Ng C, Tsang Y, Sun C, Celestino J, et al.
J Transl Med
. 2022 Dec;
20(1):606.
PMID: 36528667
Background: Low-grade serous ovarian cancer (LGSOC) is a rare disease that occurs more frequently in younger women than those with high-grade disease. The current treatment is suboptimal and a better...
7.
Gilks C, Selinger C, Davidson B, Kobel M, Ledermann J, Lim D, et al.
Int J Gynecol Pathol
. 2022 Oct;
41(Suppl 1):S119-S142.
PMID: 36305537
The move toward consistent and comprehensive surgical pathology reports for cancer resection specimens has been a key development in supporting evidence-based patient management and consistent cancer staging. The International Collaboration...
8.
Gershenson D, Cobb L, Westin S, Zhang Y, Jazaeri A, Malpica A, et al.
Gynecol Oncol
. 2022 Sep;
167(2):139-145.
PMID: 36137845
Objective: The purpose of the present study is to describe a cohort who received contemporary primary treatment for stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC), including patient characteristics and determinants...
9.
Malpica A, Euscher E, Marques-Piubelli M, Miranda R, Raghav K, Fournier K, et al.
Am J Surg Pathol
. 2022 Jun;
46(10):1352-1363.
PMID: 35713639
Localized malignant peritoneal mesothelioma is a rare tumor with limited information in the literature. In this study, we present our experience with 18 cases seen in our hospital over a...
10.
Gershenson D, Sun C, Westin S, Eyada M, Cobb L, Nathan L, et al.
Gynecol Oncol
. 2022 May;
165(3):560-567.
PMID: 35606067
Objective: Low-grade serous carcinoma (LGSOC) is a rare epithelial ovarian/peritoneal cancer characterized by younger age at diagnosis, relative chemoresistance, prolonged overall survival (OS), and mutations in the mitogen activated protein...